Through these tests, you can gain access to critical information that can help determine your overall state of health
Comparing tirzepatide (Mounjaro) and semaglutide (Ozempic, Wegovy) Both drugs show promise not only in improving metabolic health, reducing hemaglobin A1C (hbA1C), and assisting with weight lossthe data also shows that they may reduce the likelihood of cardiovascular events such as heart attack or stroke and improve cardiovascular outcomes across the board
Why Your Glasses Work Some Days and Not Others The South Florida Factor Here in Tamarac, our unique environment compounds diabetic vision challenges
Bottom Line Semaglutide is not a blood pressure medication, but research suggests it may contribute to meaningful reductions in blood pressure as a result of weight loss and improved cardiometabolic health
Learn more about managing side effects at Ivm Health
The Science You Need to Know If youve ever opened the fridge at 10 p.m